Stock Analysis
Koninklijke Philips N.V. (PHG) Stock Analysis
Koninklijke Philips N.V. (PHG) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Koninklijke Philips N.V. (PHG) currently has an AIQ Score of 72/100, indicating a bullish setup. Value is the strongest factor at 80/100. Quality is the weakest current factor at 67/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
PHG at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $29.81 |
| AIQ Score | 72/100 |
| Overall View | Bullish |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $29.66B |
| P/E Ratio (TTM) | 26.96 |
| Forward P/E | — |
| EPS (Q3 FY2026) | $0.03 |
| Revenue (Q3 FY2026) | $4.37B |
| Dividend Yield (TTM) | 3.13% |
| Beta | 0.85 |
| Volume | 1.45M |
| 52-week range | $23.62-$33.44 |
| RSI 14 | 70.88 |
| 50-Day SMA | $26.14 |
| 200-Day SMA | $27.24 |
| Analyst Price Target | — |
| Next Earnings | Feb 9, 2027 |
PHGKoninklijke Philips N.V.
Healthcare / Medical - Devices
Leader
Sector Leader
Latest quote
- Momentum72
- Value80
- Quality67
- Risk resilience73
- Sentiment—
PHG Stock Analysis Summary
Koninklijke Philips N.V. (PHG) currently has an AIQ Score of 72/100, indicating a bullish setup. Value is the strongest factor at 80/100. Quality is the weakest current factor at 67/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bullish regime, PHG has AIQ Score of 72/100 with Value base of 80/100 and fading Quality at 67/100. Wait for component alignment before adding exposure.
Healthcare · -0.27% stock move · PHG classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is PHG Bullish or Bearish Right Now?
PHG currently has a bullish overall setup. Value is the strongest factor at 80/100, while Quality is weakest at 67/100. The current evidence suggests a constructive setup.
- - Quality is supportive at 67/100.
- - Momentum is constructive at 72/100.
- - Risk Resilience is supportive at 73/100.
- - Price is +16.05% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (36 vs 5).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
PHG's Technical Analysis Consensus is currently Strong Buy, with 36 buy, 5 neutral, and 5 sell votes. PHG's 14-day RSI is 70.88, which places the stock in an overbought momentum range. PHG's beta is 0.85, indicating market sensitivity broadly in line with the market.
What Changed in PHG?
The largest recent change in PHG is Momentum moving down by 2.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the PHG Outlook?
The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
PHG Decision Framework
Public evidence layers, setup checks, and risk context for Koninklijke Philips N.V..
Koninklijke Philips N.V. (PHG) Stock Analysis
Koninklijke Philips N.V. has an AIQ Score of 72/100 in a Bullish regime. Value is strongest at 80/100. Beta is 0.85, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | PHG is in a Bullish AIQ regime with score 72/100. |
| Signal Conflict | The primary conflict is that value leads at 80/100 while quality lags at 67/100. |
| Factor Evidence | Momentum 72/100 · Value 80/100 · Quality 67/100 · Risk 73/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 80/100.
Momentum is 72/100 and RSI (14) is 70.9.
PHG is in a Bullish regime at 72/100.
Risk factor is 73/100 with beta 0.85 and annual volatility 29.69%.
Current conflict: value leads at 80/100 while quality lags at 67/100.
PHG Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
PHG Fundamentals
PHG valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
PHG Technical Analysis
PHG technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
PHG Stock Catalysts
Track PHG earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
PHG Dividend Analysis
PHG dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
PHG Financial Data
PHG revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
PHG Risk Analysis
PHG volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
PHG Stock News
PHG stock news, market tone, recent headlines, and catalyst context.
PHG vs Medical - Devices Peers
Current peer cohort: PHG · PRCT · SNN · TNDM · UFPT. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| PHG Current stock | 72/100 | 80/100 | 72/100 | 73/100 | 0.18 | 29.69% | Current |
| PRCT PROCEPT BioRobotics Corporation | 49/100 | 38/100 | 60/100 | 45/100 | -0.11 | 65.89% | PHG vs PRCT |
| SNN Smith & Nephew plc | 70/100 | 79/100 | 60/100 | 75/100 | -0.2 | 27.30% | PHG vs SNN |
| TNDM Tandem Diabetes Care, Inc. | 55/100 | 64/100 | 59/100 | 38/100 | 0.49 | 75.74% | PHG vs TNDM |
| UFPT UFP Technologies, Inc. | 68/100 | 61/100 | 81/100 | 56/100 | 0.69 | 50.83% | PHG vs UFPT |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for PHG: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 19, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching PHG
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for PHG
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
PHG Stock FAQ
What is PHG stock price today?
Koninklijke Philips N.V.'s current stock price is $29.81. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is PHG bullish or bearish right now?
PHG's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is PHG's market cap?
PHG's market cap is $29.66B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is PHG's current P/E ratio?
PHG's current P/E ratio is 26.96 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is PHG's RSI?
PHG's 14-day RSI is 70.88 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is PHG above its 50-day and 200-day moving averages?
PHG is 16.05% from its 50-day SMA and 11.38% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is PHG's next earnings date?
PHG's next earnings date is currently listed as Feb 9, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does PHG pay a dividend?
PHG's dividend yield is 3.13% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.